FDA-Inspected Site

Medical Compression Systems

2 FDA inspections are on record for Medical Compression Systems in OR Aqiva, Israel.

Clean· No action indicated

OR Aqiva, Israel · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2012-07-11.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Jul 2012Not recordedClean
23 Jun 2011Not recordedWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 Jun 2011
21 CFR 806.10(a)(1)

Report of risk to health

Cited by Thai T Duong

23 Jun 2011
21 CFR 820.22

Quality Audit/Reaudit - conducted

Cited by Thai T Duong

23 Jun 2011
21 CFR 820.30(g)

Design validation - production units

Cited by Thai T Duong

23 Jun 2011
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Thai T Duong

23 Jun 2011
21 CFR 820.180

Availability

Cited by Thai T Duong

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 806.10(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.180Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(c)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Medical Compression Systems' 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat